Centers of Biomedical Research Excellence (COBRE)

 


NCRR's Centers of Biomedical Research Excellence (COBRE) support thematic multidisciplinary centers that augment and strengthen institutional biomedical research capacity. This is accomplished by expanding and developing biomedical faculty research capability and enhancing research infrastructure, including the establishment of core facilities needed to carry out the objectives of a multidisciplinary, collaborative program.

Each COBRE includes:

1) a principal investigator who is an established biomedical or behavioral research scientist with expertise central to the research theme of the center, has an active research laboratory, has relevant peer-reviewed funding, and has demonstrated administrative leadership and mentoring experience;

2) three to five individual research projects—each supervised by a single junior investigator—that stand alone but share a common thematic scientific focus; and

3) at least one mentor for each junior investigator, and a development and mentoring plan addressing how the junior investigators will transition to competitive grant support from NIH Institutes and Centers or other Federal or non-Federal agencies or organizations.

Currently Funded COBREs in South Carolina:


COBRE in Oxidants, Redox Balance and Stress Signaling

Medical University of South Carolina

Dr. Kenneth Tew, Director

South Carolina COBRE for Cardiovascular Disease
Medical University of South Carolina
Dr. Roger Markwald, Director

Center for Colon Cancer Research
University of South Carolina

Dr. Franklin Berger, Director

South Carolina COBRE for Oral Health
Medical University of South Carolina

Dr. Keith Kirkwood, Director

COBRE in Lipidomics and Pathobiology
Medical University of South Carolina

Dr. Lina Obeid, Director

SCBIOMAT: South Carolina COBRE Center of Biomaterials for Tissue Regeneration
Clemson University
Dr. Naren Vyavahare, Director

Clinical and Translational Science Awards (CTSA)


The Clinical and Translational Science Awards (CTSA) program supports a national consortium of medical research institutions that are transforming the way biomedical research is conducted. Its goals are to accelerate the translation of laboratory discoveries into treatments for patients, to engage communities in clinical research efforts, and to train a new generation of clinical and translational researchers.


South Carolina is the recipient of one CTSA located at the Medical University of South Carolina. The South Carolina Clinical and Translational Research Institute (SCTR) is the catalyst for changing the culture of biomedical research, facilitating sharing of resources and expertise, and streamlining research-related processes to bring about large-scale, change in the clinical and translational research efforts in South Carolina.